Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pirfenidone: A Novel Anti-Scarring Therapy for Diabetic Nephropathy

NCT00063583 is registered in ClinicalTrials.gov with Sharma, Kumar, M.D. as lead sponsor.

NCT NCT00063583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00063583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pirfenidone: A Novel Anti-Scarring Therapy for Diabetic Nephropathy
Lead sponsor
Sharma, Kumar, M.D.
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2003
Completion date
March 31, 2009
Enrollment
77 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic nephropathy